Market Research Logo

Global In-situ Hybridization (ISH) Market 2017-2021

Global In-situ Hybridization (ISH) Market 2017-2021

About In-Situ Hybridization (ISH)

ISH is a technique for localizing specific nucleic acid targets within fixed tissues and cells, providing temporal and spatial information about gene expression and genetic loci. While the basic workflow of ISH is similar to that of blot hybridizations, the nucleic acid probe is synthesized, labeled, purified, and annealed with the specific target; the difference is the greater amount of information gained by visualizing the results within the tissue. Technavio’s analysts forecast the global in-situ hybridization (ISH) market to grow at a CAGR of 6.59% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global in-situ hybridization (ISH) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of reagents and instruments used to conduct ISH.The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global In-situ Hybridization (ISH) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
Other prominent vendors
  • Advanced Cell Diagnostics
  • Biocare Medical
  • Bio SB
  • BioDot
  • BioGenex
  • Cytocell
  • Exiqon
  • Genemed Biotechnologies
  • LGC Biosearch Technologies
  • Leica Biosystems
  • Merck
  • Mirius Bio
  • PerkinElmer
Market driver
  • Growing incidence and prevalence of cancer
  • For a full, detailed list, view our report
Market challenge
  • Emergence of alternative techniques
  • For a full, detailed list, view our report
Market trend
  • Increasing M&A activity in molecular diagnostics market
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Releases

Technavio Announces the Publication of its Research Report – Global In-situ Hybridization (ISH) Market 2017-2021

Technavio recognizes the following companies as the key players in the global in-situ hybridization (ISH) market: Abbott, Agilent Technologies, F. Hoffmann-La Roche, and Thermo Fisher Scientific

Other Prominent Vendors in the market are: Advanced Cell Diagnostics, Biocare Medical, Bio SB, BioDot, BioGenex, Cytocell, Exiqon, Genemed Biotechnologies, LGC Biosearch Technologies, Leica Biosystems, Merck, Mirius Bio, and PerkinElmer.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Increasing M&A activity in molecular diagnostics market. Diagnostic companies are progressively seeking strategic opportunities to enhance their competencies in the molecular diagnostics sector and tap into the market’s growth potential. The global molecular diagnostics market is poised to grow at a high rate and reach over $7 billion by 2022. Industry experts and KOLs believe that PCR, NGS, microarray, and ISH, especially FISH, are the dominant technologies in the space. Particularly for ISH, a major trend of partnerships is being observed as one company focuses on developing the therapy for a drug, while the other company focuses on developing the companion diagnostic test. Both companies benefit immensely from such deals as a synergistic growth opportunity is seen along with portfolio expansion.”

According to the report, one of the major drivers for this market is Growing incidence and prevalence of cancer. Globally, cancer is among the top five causes of death across all age groups. The various types of cancer contribute to significant deaths across all regions in the world. However, the low and middle-income countries are the worst-affected regions. Cancer caused by tobacco is the most common type of cancer in these countries, which is also the most-easily preventable.

Further, the report states that one of the major factors hindering the growth of this market is Emergence of alternative techniques. Although FISH provides considerable cost benefit and superior performance when compared with other molecular IVD tests, full-scale adoption of this technique is lacking in routine IVD use. When applied to complex samples such as mucoid respiratory samples, results are highly irregular and the procedure intrinsically complex. Although some advancements have been made which remove traditional DNA probes with peptide probes, the resulting IVD assays till date have only managed to address niche markets.

Companies Mentioned

Abbott, Agilent Technologies, F. Hoffmann-La Roche, Thermo Fisher Scientific, Advanced Cell Diagnostics, Biocare Medical, Bio SB, BioDot, BioGenex, Cytocell, Exiqon, Genemed Biotechnologies, LGC Biosearch Technologies, Leica Biosystems, Merck, Mirius Bio, and PerkinElmer.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Differences between CISH and FISH
      • Table Snapshot: Overview of global ISH market
  • Market landscape
    • Market size and forecast
      • Table Global ISH market 2016-2021 ($ millions)
      • Table Factors affecting global ISH market and their level of impact
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by technology
    • Market overview
      • Table Global ISH market by technology 2016 and 2021 (% share)
      • Table Snapshot: Overview of global ISH market by technology
    • FISH
      • Table Global FISH market 2016-2021 ($ millions)
    • CISH
      • Table Global CISH market 2016-2021 ($ millions)
  • Market segmentation by end-user
    • Market overview
      • Table Global ISH market by end-user 2016 and 2021 (% share)
      • Table Snapshot: Overview of global ISH market by end-user
    • Molecular diagnostic laboratories
      • Table Global ISH market by molecular diagnostic laboratories 2016-2021 ($ millions)
    • Pharmaceutical and biotechnology companies
      • Table Global ISH market by pharmaceutical and biotechnology companies 2016-2021 ($ millions)
    • Others
      • Table Global ISH market by others 2016-2021 ($ millions)
  • Geographical segmentation
    • Market overview
      • Table Global ISH market by geography 2016 and 2021 (% share)
      • Table Snapshot: Overview of global ISH market by geography
    • ISH market in Americas
      • Table ISH market in Americas 2016-2021 ($ millions)
    • ISH market in EMEA
      • Table ISH market in EMEA 2016-2021 ($ millions)
    • ISH market in APAC
      • Table ISH market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table List of FDA-approved companion diagnostic tests using ISH
      • Table Personalized medicine and key statistics from FDA approvals of NMEs
      • Table Advantages of FISH in detection of foodborne pathogens as compared with conventional methods
    • Market challenges
      • Table Head-to-head comparison between traditional FISH and DMI
  • Market trends
    • Increasing M&A activity in molecular diagnostics market
    • National initiatives across the globe spurring molecular research activities
    • Increasing importance of promotional activities
  • Vendor landscape
    • Competitive scenario
      • Table Strategic success factors currently being followed by vendors
    • Investment opportunity
      • Table Investment opportunity mapping
  • Key vendor analysis
    • Abbott
      • Table Abbott: Profile
      • Table Abbott: Strength analysis
      • Table Abbott: Strategy assessment
      • Table Abbott: Opportunity assessment
    • Agilent Technologies
      • Table Agilent Technologies: Profile
      • Table Agilent Technologies: Strength analysis
      • Table Agilent Technologies: Strategy assessment
      • Table Agilent Technologies: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Profile
      • Table F. Hoffmann-La Roche: Strength analysis
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific: Profile
      • Table Thermo Fisher Scientific: Strength analysis
      • Table Thermo Fisher Scientific: Strategy assessment
      • Table Thermo Fisher Scientific: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report